Molecular Mechanism of Inhibition of Survivin Transcription by the GC-rich Sequence-selective DNA Binding Antitumor Agent, Hedamycin
Open Access
- 1 March 2005
- journal article
- Published by Elsevier BV
- Vol. 280 (10), 9745-9751
- https://doi.org/10.1074/jbc.m409350200
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cellsOncogene, 2004
- Survivin, versatile modulation of cell division and apoptosis in cancerOncogene, 2003
- Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cellsCancer Gene Therapy, 2003
- Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF-7 cellsCancer Gene Therapy, 2003
- IAP proteins: blocking the road to death's doorNature Reviews Molecular Cell Biology, 2002
- DNA and its associated processes as targets for cancer therapyNature Reviews Cancer, 2002
- Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosisJCI Insight, 2002
- Expression and Targeting of the Apoptosis Inhibitor, Survivin, in Human MelanomaJournal of Investigative Dermatology, 1999
- Effect of DNA-binding Drugs on Early Growth Response Factor-1 and TATA Box-binding Protein Complex Formation with the Herpes Simplex Virus Latency PromoterPublished by Elsevier BV ,1996
- Molecular Cloning and Chromosomal Localization of the Human Cyclin C (CCNC) and Cyclin E (CCNE) Genes: Deletion of theCCNCGene in Human TumorsGenomics, 1996